xmlns:blogChannel="http://backend.userland.com/blogChannelModule" > no All Worldwide Medical & Health Events powered by HON. Stay uptodate on the evolution of the health/medical conferences and events on Psychopharmacology. Consult national & international medical health events'reposotory offered by HON. HONwebmaster@healthonnet.org webmaster@healthonnet.org http://www.hon.ch/Conf/Theme/F04.096.712.html Stay uptodate on the evolution of the health/medical conferences and events on Psychopharmacology. Consult national & international medical health events'reposotory offered by HON. en-fr-it Copyright 2006, HON webmaster@healthonnet.org http://www.hon.ch/cgi-bin/confevent?aff2+CONF11889 ]]>The science covered will include the latest findings inresearch in psychopharmacology. In addition a strongemphasis on education with our dedicated educational trackwill be available to all delegates. Suggestions receivedwill be independently selected by our InternationalScientific Programme Committee thus ensuring the continuedhigh calibre meeting that CINP is renowned for. 03 Jun 2012 08:00:00 +0000 http://www.hon.ch/cgi-bin/confevent?aff2+CONF11890 ]]>Organized around the theme Psychology Serving Humanity, thecongress will highlight how psychology translates its science and practice into the knowledge, skills and tools that are able to underpin the human condition. Special activities will include an exciting Emerging Psychologists'Programme, Advanced Research Training Seminars forpsychologists from the developing world, various pre andpost congress satellite conferences and a variety of tours. 22 Jul 2012 08:00:00 +0000 http://www.hon.ch/cgi-bin/confevent?aff2+CONF12775 ]]>On behalf of the European Society for the Study of Personality Disorder (ESSPD) we would like to welcome you to the 2nd International Congress on Borderline Personality Disorder. Research on borderline personality disorder (BPD) and allied disorders has increased dramatically in the last few years, increasing our knowledge of the development of the disorder, its treatment and long-term outcome. Yet there remains a mismatch between our understanding of the disorder, so often associated with other psychiatric disorders, treatment demand, and the provision of clinical services. Distinguished speakers will discuss the latest developments in our understanding of the genesis of the disorder, consider its association with impulse, post traumatic stress and emotional dysregulation disorders, deliberate on the complexity of treatment, and reflect about the economic costs and social consequences of the disorder. The conference will appeal to basic scientists, clinicians, patients, health service managers and others. So we look forward to welcoming everyone who is interested in borderline personality disorder and allied disorders, whatever their perspective. Join us in this wonderful city in September 2012. Contact: CPO HANSER SERVICE GmbH Congress - and Exhibition Office Zum Ehrenhain 34 22885 Barsbuttel Germany Tel.: +49-40-670 882 - 0 Fax: 49-40-670 32 83 Email: borderline2012@cpo-hanser.de Dates to remember: January 31, 2012 - Abstract submission deadline for Symposia and Workshops March 16, 2012 - Abstract submission deadline for Oral Presentations and Posters May 31, 2012 - Deadline early registration fee September 24, 2012 - End of online registration Keynote Speaker John Gunderson BPD long term outcome and prognosis Jan van Busschbach A health economic view on (borderline) personality disorder Christian Schmahl Neurobiology and social interaction in BPD Marsha Linehan Emotion regulation in Dialectical Behavioral Treatment Andrew Chanen Early detection and prevention Klaus Lieb Metaanalyses on psychotherapy outcome and the effectiveness of general psychiatric care 27 Sep 2012 08:00:00 +0000 http://www.hon.ch/cgi-bin/confevent?aff2+CONF12876 ]]>The program will provide an up to date introduction to pharmacogenomics and personalised medicine in psychiatry for general psychiatrists as well as an opportunity to exchange the latest data for specialists and researchers inthe area. Because of the intense interest of the pharmaceutical industry in prediction of response to psychotropic drugs and the critical importance of adverse event prediction, we expect that the Thematic Meeting will be the focus of several critical industry related events. Ethical, economic, social and legal aspects will be considered as well the implementation of personalised medicine in clinical practice. 21 Apr 2013 08:00:00 +0000